Advisors Asset Management, Inc. Standard Biotools Inc. Transaction History

Advisors Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$4.34 - $11.43 $7,885 - $20,768	-1,817 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$1.85 - $5.29 $68 - $195	-37 Reduced 2.0%	1,817 $7,000
Q1 2020 May 15, 2020	SELL	$1.24 - $4.35 $324 - $1,139	-262 Reduced 12.38%	1,854 $5,000
Q4 2019 Feb 14, 2020	SELL	$2.3 - $5.12 $73 - $163	-32 Reduced 1.49%	2,116 $7,000
Q3 2019 Nov 14, 2019	BUY	$4.63 - $12.15 $912 - $2,393	197 Added 10.1%	2,148 $10,000
Q2 2019 Aug 14, 2019	BUY	$11.49 - $14.17 $22,416 - $27,645	1,951 New	1,951 $24,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $131M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.